3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
19
Glioblastoma
18
Breast Neoplasms
18
Squamous Cell Carcinoma of Head and Neck
15
Lung Neoplasms
12
Rectal Neoplasms
11
Oropharyngeal Neoplasms
10
Neoplasms
9
Head and Neck Neoplasms
9
Glioma
8
Astrocytoma
8
Neoplasm Metastasis
7
Sarcoma
6
Esophageal Neoplasms
6
Carcinoma, Squamous Cell
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Lymphoma, Follicular
5
Hodgkin Disease
5
Gliosarcoma
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Carcinoma
5
Burkitt Lymphoma
5
Brain Neoplasms
5
Adenocarcinoma of Lung
5
Adenocarcinoma Of Esophagus
5
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Radiotherapy
×
90 days
×
Clear all
No trials found.